FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formula and their pharmaceutically acceptable salts possessing antibacterial properties, as well as to a based pharmaceutical composition. In formula (I) R1 represents an alkoxy group; each of U and V represents CH, and W represents N, or U represents N, V represents CH and W represents CH or N, or each of U and V represents N, and W represents CH; R2 represents hydrogen or fluorine, if W represents CH, or R2 represents hydrogen, if W represents N; A represents O or CH2; Y represents CH or N; Q represents O or S; and n represents 0 or 1.
EFFECT: preparing the pharmaceutically acceptable salts possessing the antibacterial properties.
23 cl, 3 tbl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
5-AMINO-2-(1-HYDROXYETHYL)TETRAHYDROPYRAN DERIVATIVES | 2009 |
|
RU2525541C2 |
5-AMINOCYCLYLMETHYLOXAZOLIDIN-2-ONE DERIVATIVES | 2008 |
|
RU2492169C2 |
OXAZOLIDINE ANTIBIOTICS | 2009 |
|
RU2516701C2 |
ANTIBIOTIC DERIVATIVES OF 2-OXO-OXAZOLIDINE-3, 5-DIYL | 2012 |
|
RU2616609C2 |
TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS | 2009 |
|
RU2530884C2 |
[4-(1-AMINOETHYL)CYCLOHEXYL]METHYLAMINE AND [6-(1-AMINOETHYL)TETRAHYDROPYRAN-3-YL]METHYLAMINE DERIVATIVES | 2009 |
|
RU2515906C2 |
ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2797295C1 |
COMPOUNDS WITH CONDENSED RINGS | 2019 |
|
RU2783414C2 |
COMBINED TREATMENT BY A TOLL-LIKE RECEPTOR (TLR7) AGONIST AND A HEPATITIS B VIRUS CAPSID ASSEMBLY INHIBITOR | 2016 |
|
RU2718917C2 |
BENZOXEPIN PI3 INHIBITORS AND METHODS FOR USING THEM | 2010 |
|
RU2557658C2 |
Authors
Dates
2015-02-10—Published
2010-04-08—Filed